MediPharm Labs Corp. (LABS.TO)

CAD 0.06

(-7.69%)

Revenue Summary of MediPharm Labs Corp.

MediPharm Labs Corp.'s latest annual revenue in 2023 was 33.06 Million CAD , up 49.49% from previous year.
MediPharm Labs Corp.'s latest quarterly revenue in 2024 Q2 was 10.35 Million CAD , up 5.93% from previous quarter.
MediPharm Labs Corp. reported a annual revenue of 22.11 Million CAD in annual revenue 2022, up 1.87% from previous year.
MediPharm Labs Corp. reported a annual revenue of 21.71 Million CAD in annual revenue 2021, down -39.71% from previous year.
MediPharm Labs Corp. reported a quarterly revenue of 9.77 Million CAD for 2024 Q1, up 7.01% from previous quarter.
MediPharm Labs Corp. reported a quarterly revenue of 33.06 Million CAD for 2023 FY, up 49.49% from previous quarter.

Annual Revenue Chart of MediPharm Labs Corp. (2023 - 2016)

Historical Annual Revenue of MediPharm Labs Corp. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	33.06 Million CAD	49.49%
2022	22.11 Million CAD	1.87%
2021	21.71 Million CAD	-39.71%
2020	36.01 Million CAD	-72.14%
2019	129.25 Million CAD	1167.42%
2018	10.19 Million CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	10.35 Million CAD	5.93%
2024 Q1	9.77 Million CAD	7.01%
2023 FY	33.06 Million CAD	49.49%
2023 Q4	9.13 Million CAD	7.36%
2023 Q3	8.5 Million CAD	-11.25%
2023 Q2	9.58 Million CAD	64.01%
2023 Q1	5.84 Million CAD	4.04%
2022 Q1	4.87 Million CAD	-15.08%
2022 FY	22.11 Million CAD	1.87%
2022 Q4	5.61 Million CAD	-22.67%
2022 Q3	7.26 Million CAD	66.48%
2022 Q2	4.36 Million CAD	-10.56%
2021 FY	21.71 Million CAD	-39.71%
2021 Q4	5.74 Million CAD	6.33%
2021 Q3	5.4 Million CAD	6.49%
2021 Q2	5.07 Million CAD	-7.7%
2021 Q1	5.49 Million CAD	-9.29%
2020 Q3	4.94 Million CAD	-64.46%
2020 Q2	13.91 Million CAD	25.51%
2020 Q1	11.08 Million CAD	-65.82%
2020 FY	36.01 Million CAD	-72.14%
2020 Q4	6.05 Million CAD	22.46%
2019 FY	129.25 Million CAD	1167.42%
2019 Q3	43.38 Million CAD	37.86%
2019 Q2	31.47 Million CAD	43.38%
2019 Q1	21.95 Million CAD	115.24%
2019 Q4	32.44 Million CAD	-25.22%
2018 Q4	10.19 Million CAD	0.0%
2018 Q2	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 FY	10.19 Million CAD	0.0%
2018 Q3	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q3	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q1	- CAD	0.0%
2017 Q4	- CAD	0.0%
2016 FY	- CAD	0.0%

Peer Revenue Comparison of MediPharm Labs Corp.

Name	Revenue	Revenue Difference
Aurora Cannabis Inc.	270.28 Million CAD	87.768%
Avicanna Inc.	16.79 Million CAD	-96.897%
Avant Brands Inc.	26.34 Million CAD	-25.501%
Cardiol Therapeutics Inc.	- CAD	-Infinity%
Crescita Therapeutics Inc.	17.52 Million CAD	-88.689%
Knight Therapeutics Inc.	328.19 Million CAD	89.926%
OrganiGram Holdings Inc.	149.2 Million CAD	77.841%
Canopy Growth Corporation	297.14 Million CAD	88.873%
Willow Biosciences Inc.	1.17 Million CAD	-2720.99%
Auxly Cannabis Group Inc.	101.07 Million CAD	67.291%